Showing results (481-490 of 2,398) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|October 16, 2025
"Safety and efficacy of early drain removal in breast reconstruction: a retrospective cohort study"Daiju Goto, Azusa Oshima, Tatsuya Onishi, et al.
Breast Cancer (Tokyo, Japan)|October 2, 2025
Characterization of gut microbiota dysbiosis in breast cancer patientsMai Yamada, Makoto Kubo, Kazuhisa Kaneshiro, et al.
Breast Cancer (Tokyo, Japan)|May 10, 2020
Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancerAline Baltres, Zeina Al Masry, Ryad Zemouri, et al.
Breast Cancer (Tokyo, Japan)|August 27, 2021
Integrated analysis of cell cycle-related genes in HR+/HER2- breast cancerJianguo Lai, Bo Chen, Yingzi Li, et al.
Breast Cancer (Tokyo, Japan)|April 25, 2020
Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genesArwa Alkaraki, Walhan Alshaer, Suha Wehaibi, et al.
Breast Cancer (Tokyo, Japan)|September 7, 2021
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancerNaruto Taira, Kosuke Kashiwabara, Junji Tsurutani, et al.
Breast Cancer (Tokyo, Japan)|September 27, 2025
The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathwayMaryam Hossein Rezaei, Manzumeh Shamsi Meymandi, Amirhossein Moslemizadeh, et al.
Breast Cancer (Tokyo, Japan)|September 22, 2025
Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancerManabu Futamura, Yasuko Nagao, Yukiko Takai, et al.
Breast Cancer (Tokyo, Japan)|September 16, 2025
Prevalence of germline CHEK2 variants in East Asians and Koreans based on population genomic databasesJong Eun Park, Taeheon Lee, Eun Hye Cho, et al.
Breast Cancer (Tokyo, Japan)|September 12, 2025
C-type lectin-like domain family 2 (CLEC2D) promotes proliferation and migration of breast cancer and serves as a poor prognostic factorMio Yamaguchi-Tanaka, Yui Kurihara, Kiyoshi Takagi, et al.
Pageof 240